The advent of COVID-19 has brought unprecedented global disruption and loss in ways never imagined. Equally unprecedented has been the pace at which the life sciences industry is developing medical and technology-driven solutions to combat this devastating virus. Join BioNJ and industry experts, including Quality Institute President & CEO, Linda Schwimmer, to reflect upon observations, learnings and projections, as well as short- and long-term opportunities for medical innovation and the industry overall.
Register today and plan to join fellow executives, investors, entrepreneurs, academics and other members of the diverse and ever-evolving life sciences community at BioNJ’s Virtual C-Suite Summit for learning and networking from the safety of your personal workspace.
Registration is $250 for BioNJ Members and $350 for Future BioNJ Members. BioNJ Member Companies can purchase 3 or more registrations for the special price of $575. Click here to register.
|*||Innovation and New World Order – Reflections, Learnings and Global Short & Long Term Implications Presented by McKinsey & Company|
|Fireside Chat on “The ‘New Normal’ – Transition, Recovery and Beyond” with Moderna Leaders|
|*||The Regulatory Horizon – COVID-19 Accommodations and Moving Forward|
|*||Fireside Chat: Navigating Innovation & Uncertainty from the Top – With a World View of the Industry|
|*||Panel: The Financial Environment|
|*||Panel Discussion: COVID-19 – Driven Technology Transformation and the Patient|
|*||Fireside Chat: Data Analytics and Solving for the Future|